Skip to content

    Transpek Inds.

    Vadodara-based manufacturer of chlorinated and sulphur-based specialty chemicals (acid chlorides, alkyl chlorides) supplying pharma, agrochemical, polymer, dye and cosmetics industries worldwide.

    Chemicals
    Commodities
    View 506687 earnings calls

    Overview

    Price

    Market Cap

    ₹595 Cr

    Sector

    Chemicals

    Commodities

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital66666666
    Reserves333374479581668740762762
    Borrowings116111137145123944160
    Other Liabilities134109143155169161191181
    Total Liabilities5895997648879661.0k1.0k1.0k
    AssetsFixed Assets287287295365397360342343
    CWIP1914162465135
    Investments118142196238321328335316
    Other Assets166156258260242307310344
    Total Assets5895997648879661.0k1.0k1.0k

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating128111354711198135
    Cash from Investing-45-33-17-70-13-32-30
    Cash from Financing-83-77-39-94-64-56
    SummaryCapital Expenditure
    Free Cash Flow80742096660116
    FCF Margin

    Valuation

    Assumptions

    Current — 506687
    Price
    ₹1,015
    EPS (TTM)
    ₹81.72
    PE (TTM)
    12.4
    Profit growth
    -18.2%

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (16.7×) and current (12.4×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹1,015
    vs
    Fair value · 15% return
    ₹134
    87%Overvalued

    At -18.2% growth and a 12× exit, ₹1015 only delivers your return if you pay ₹134. The price is currently baking in 18% growth.

    EPS grows -18.2%/yr for 5 years, then fades to 6% over 2, exits at 12×.

    YearGrowthEPS (₹)
    FY27-18.2%66.85
    FY28-18.2%54.68
    FY29-18.2%44.73
    FY30-18.2%36.59
    FY31-18.2%29.93
    FY32-6.1% ·fade28.10
    FY336.0% ·fade29.79

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Transpek Inds.

    Guides on how to read this kind of business and the numbers that matter.